Frontiers in Immunology (Mar 2024)
Corrigendum: CD44 targeted delivery of oncolytic Newcastle disease virus encapsulated in thiolated chitosan for sustained release in cervical cancer: a targeted immunotherapy approach
Abstract
No abstracts available.Keywords